Hedge-fund billionaire John Paulson has joined the board of Valeant Pharmaceuticals, a sign that the investor remains bullish on the drugmaker’s prospects despite accruing steep losses on investments in the firm.
from WSJ.com: US Business http://ift.tt/2sKhuXZ
via IFTTT
No comments:
Post a Comment